Quantcast
Channel: Daily Bankrupt Company Updates | Bankrupt Company News
Viewing all articles
Browse latest Browse all 4593

BIND Therapeutics Chapter 11 Petition Filed

0
0

According to the U.S. Bankruptcy Court docket, BIND Therapeutics and BIND Biosciences Security filed for Chapter 11 protection in Wilmington, DE.

On April 6, 2016, BIND Therapeutics announced a restructuring plan designed to streamline operations and reduce operating expenses. The restructuring included a workforce reduction of 38%. In addition to the workforce reduction initiatives, the Company also announced that it was reviewing financial and strategic alternatives with the goal of maximizing stockholder value. A corporate release notes, “Potential alternatives to be explored and evaluated during the review process may include raising additional capital, a strategic collaboration with one or more parties, or the licensing, sale or divestiture of some of the Company’s proprietary technologies.”

The Company, which is a clinical-stage nanomedicine platform company, is represented by John Henry Knight of Richards, Layton & Finger. Read more bankruptcy news.

 

 

The post BIND Therapeutics Chapter 11 Petition Filed appeared first on Daily Bankrupt Company Updates | Bankrupt Company News.


Viewing all articles
Browse latest Browse all 4593

Latest Images

Trending Articles





Latest Images